Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Osheiza Abdulmalik, PhD
Research Associate II
Perelman School of Medicine
University of Pennsylvania
3615 Civic Center Blvd
Abramson Research Center
Philadelphia, Pennsylvania, United States
Dr. Abdulmalik’s research interests broadly encompass the hemoglobinopathies and red blood cell disorders, with particular focus on sickle cell disease and beta-thalassemia. Though both disorders are consequences of simple genetic mutations, the implications of these mutations are inherently complex, and include significant morbidities, lifelong challenges, reduced quality of life, and early mortality in patients; as well as substantial healthcare burden on families, caregivers, and society in general.
Dr. Abdulmalik’s current research focuses on three modalities of countering disease pathophysiology. The first approach, in tandem with a multidisciplinary team of collaborators, utilizes medicinal chemistry and structural biology to design novel drugs that block the primary pathophysiology of sickle cell disease, i.e., the polymerization of sickle hemoglobin.
Z. Jim Wang, PhDDr. Wang is a professor of pharmacology ...
Julie A. Panepinto, MD, MSPHJulie Panepinto is a professor of pediat...
IU Nurse Invents Medical Device for People With Sickle Cell Diseasehttps://www.youtube.com/watch?v=TjE3Urth...
How to improve sickle cell care in emergency medicine: A case reviewIn this interview, Dr. Bernard Lopez fro...
Doris Duke Charitable Foundation awards grant to Critical Path InstituteIn a continuing effort to spur advance...
Sickle Cell Center of Southern LouisianaThe Tulane University Sickle Cell Center...
American Sickle Cell Anemia AssociationThe American Sickle Cell Anemia Associat...